CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of cardiac diseases
3.4.1.2. Rise in incidence of trauma and accidents
3.4.2. Restraints
3.4.2.1. High cost associated with implant procedure
3.4.3. Opportunities
3.4.3.1. Rise in adoption of key strategies
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Orthopedic Bionics
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Orthopedic Bionics Artificial Organs and Bionic Implants Market by Orthopedic Bionics Type
4.3. Ear Bionics
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Others
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Electronic
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Mechanical
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Technology
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Technology
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Technology
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Technology
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Technology
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Technology
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Technology
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Technology
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Technology
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Technology
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Technology
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Technology
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Technology
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Technology
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Technology
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Technology
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Technology
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Technology
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Technology
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Technology
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Technology
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Technology
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Technology
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Berlin Heart GmbH
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Key strategic moves and developments
9.2. Zimmer Biomet Holding Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Boston Scientific Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Cochlear Limited
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Edwards Lifesciences Corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Jarvik Heart, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Abbott Laboratories
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. SynCardia Systems LLC
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Medtronic plc
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Johnson & Johnson
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ORTHOPEDIC BIONICS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GLOBAL ORTHOPEDIC BIONICS ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY ORTHOPEDIC BIONICS TYPE, 2022-2032 ($MILLION)
TABLE 04. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR EAR BIONICS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 07. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ELECTRONIC, BY REGION, 2022-2032 ($MILLION)
TABLE 08. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR MECHANICAL, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 10. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 19. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 20. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 21. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 23. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 26. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 29. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 32. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 33. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 36. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 39. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 42. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 45. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 54. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 55. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 56. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 57. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 58. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 60. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 63. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 64. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 72. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 73. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 76. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 79. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 81. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 82. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 87. BERLIN HEART GMBH: KEY EXECUTIVES
TABLE 88. BERLIN HEART GMBH: COMPANY SNAPSHOT
TABLE 89. BERLIN HEART GMBH: PRODUCT SEGMENTS
TABLE 90. BERLIN HEART GMBH: PRODUCT PORTFOLIO
TABLE 91. BERLIN HEART GMBH: KEY STRATERGIES
TABLE 92. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 93. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 94. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
TABLE 95. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 96. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
TABLE 97. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 98. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 99. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 100. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 101. COCHLEAR LIMITED: KEY EXECUTIVES
TABLE 102. COCHLEAR LIMITED: COMPANY SNAPSHOT
TABLE 103. COCHLEAR LIMITED: PRODUCT SEGMENTS
TABLE 104. COCHLEAR LIMITED: PRODUCT PORTFOLIO
TABLE 105. COCHLEAR LIMITED: KEY STRATERGIES
TABLE 106. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 107. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 108. EDWARDS LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
TABLE 109. EDWARDS LIFESCIENCES CORPORATION: SERVICE SEGMENTS
TABLE 110. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 111. EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGIES
TABLE 112. JARVIK HEART, INC.: KEY EXECUTIVES
TABLE 113. JARVIK HEART, INC.: COMPANY SNAPSHOT
TABLE 114. JARVIK HEART, INC.: PRODUCT SEGMENTS
TABLE 115. JARVIK HEART, INC.: PRODUCT PORTFOLIO
TABLE 116. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 117. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 118. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 119. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 120. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 121. SYNCARDIA SYSTEMS LLC: KEY EXECUTIVES
TABLE 122. SYNCARDIA SYSTEMS LLC: COMPANY SNAPSHOT
TABLE 123. SYNCARDIA SYSTEMS LLC: PRODUCT SEGMENTS
TABLE 124. SYNCARDIA SYSTEMS LLC: PRODUCT PORTFOLIO
TABLE 125. SYNCARDIA SYSTEMS LLC: KEY STRATERGIES
TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 130. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 131. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 132. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 133. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 134. JOHNSON & JOHNSON: KEY STRATERGIES
List of Figures
FIGURE 01. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET
FIGURE 10. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ORTHOPEDIC BIONICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR EAR BIONICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ELECTRONIC, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR MECHANICAL, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET BY REGION, 2022
FIGURE 22. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 23. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 24. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 25. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 26. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 27. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 28. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 29. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 30. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 31. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 32. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 33. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 34. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 35. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 36. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 37. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 38. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 45. COMPETITIVE DASHBOARD
FIGURE 46. COMPETITIVE HEATMAP: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET
FIGURE 47. TOP PLAYER POSITIONING, 2022
FIGURE 48. ZIMMER BIOMET HOLDING INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 49. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 50. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 51. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 52. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 54. COCHLEAR LIMITED: NET SALES, 2020-2022 ($MILLION)
FIGURE 55. COCHLEAR LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 56. COCHLEAR LIMITED: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 57. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 58. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 59. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 60. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
FIGURE 66. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)